Results 161 to 170 of about 7,123 (225)

CAR-T manufacturing reduces heterogeneity between CIDP and multiple myeloma patient-derived T cells. [PDF]

Theranostics
Wang X, Wang P, Zhou Q, Wei X, Jin Y, Liao Y, Zhao X, Hou R, Li S, Guan Z, Ma W, Liu D, Shi M.   +12 more
europepmc   +1 more source

Plasma neurofilament light chain is associated with clinical instability in chronic autoimmune neuropathies. [PDF]

Sci Rep
Glāzere I, Roddate M, Žukova V, Kurjāne N, Blennow K, Zetterberg H, Ķēniņa V.   +6 more
europepmc   +1 more source

Clinical features and pathogenesis of Sjogrens disease related peripheral neuropathy and their relevance to clinical trials. [PDF]

Commun Med (Lond)
Pucino V, Nayar S, Fehmi J, Baldini C, Bowman SJ, Fisher BA.   +5 more
europepmc   +1 more source

Clinical course and prognosis of chronic autoimmune neuropathies requiring intensive care: a retrospective cohort study. [PDF]

J Neurol
Preßler H, Schwarz L, Streit S, Aigner A, Schleicher A, Stascheit F, Arlt FA, Zinnow V, Khorassani T, Prüss H, Böhmerle W, Meisel A, Stenzel W, Scheibe F.   +13 more
europepmc   +1 more source

Intravenous methylprednisolone as add-on induction therapy for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. [PDF]

J Neurol Neurosurg Psychiatry
Bus SRM, van Doorn IN, Zambreanu L, Wieske L, Bogaards JA, Abbas A, Rajabally YA, Vrancken AFJE, van Doorn PA, Hadden RDM, Verhamme C, de Haan RJ, de Borgie CAJM, van Schaik IN, Lunn MP, Eftimov F, OPTIC study group.   +16 more
europepmc   +1 more source

Incidence, Prevalence, and Treatment Patterns in Chronic Inflammatory Demyelinating Polyneuropathy: Data Analysis of US Claims. [PDF]

Neuroepidemiology
Gable KL, Arackal J, Edwards Y, Schwinn J, Venker B, Miller-Wilson LA.   +5 more
europepmc   +1 more source

Ofatumumab in chronic inflammatory demyelinating polyradiculoneuropathy associated with monoclonal gammopathy of undetermined significance: a case report. [PDF]

Front Immunol
Deng M, Xiong J, Kong Z, Yu Y, Li T.
europepmc   +1 more source

Practical Approach to Managing SCIg Treatment in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. [PDF]

Muscle Nerve
Vu T, Guerra C, Suresh N, Khella S, Morrell J, Pulley M, Jiang N, Sharma K, Bertorini T, Jerath N, Peltier A.   +10 more
europepmc   +1 more source

Immunotherapy in Chronic Inflammatory Demyelinating Polyneuropathy and the Emerging Role of Efgartigimod. [PDF]

J Clin Neurol
Park JS, Kang M.
europepmc   +1 more source

Aberrant Complement Activation Is a Prominent Feature of Chronic Inflammatory Demyelinating Polyneuropathy. [PDF]

Neurol Neuroimmunol Neuroinflamm
Stascheit F, Preßler H, Stein K, Pernice HF, Hahn K, Meisel A, Lünemann JD.   +6 more
europepmc   +1 more source